Pfizer is paying $44 million to settle a Chantix lawsuit. See who could get money

Pharmaceutical company Pfizer has agreed to a $44 million class action settlement over its oral prescription medication Chantix. The drug which was first approved by the FDA in May 2006 and was used to help smokers quit until it was taken off the market in 2021. The lawsuit claims that prescription medication was contaminated with high levels of a certain nitrosamine, a known carcinogen that may raise the risk of developing cancer. The suit also alleged “Pfizer failed to comply with cur...